ABILIFY



Trademark Coverage

No Class Specified

Pharmaceutical preparations for the treatment [ and prevention ] of [ cardiovascular diseases, ] central nervous system diseases and disorders [, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, antibiotics ]

Owners
Timeline
  • Aug 02
    2013
    Notice Of Acceptance Of SEC 8 & 9 E Mailed
  • Aug 02
    2013
    Registered And Renewed (First Renewal 10 Yrs)
  • Aug 02
    2013
    Registered SEC 8 (10 Yr) ACCEPTED/SEC 9 Granted
  • Aug 02
    2013
    Case Assigned To Post Registration Paralegal
  • Jul 19
    2013
    TEAS Section 8 & 9 Received
  • Nov 18
    2008
    Registered SEC 8 (6 Yr) Accepted & SEC 15 ACK
  • Nov 04
    2008
    Assigned To Paralegal
  • Oct 24
    2008
    Registered SEC 8 (6 Yr) & SEC 15 Filed
  • Oct 24
    2008
    Paper Received
  • Mar 10
    2008
    Review Of Correspondence Complete
  • Mar 05
    2008
    Paper Received
  • Jan 30
    2008
    Automatic Update Of Assignment Of Ownership
  • Jan 31
    2006
    Amendment Under Section 7 Issued
  • Dec 01
    2005
    Assigned To Paralegal
  • Aug 15
    2005
    SEC 7 Request Filed
  • Aug 15
    2005
    Paper Received
  • Oct 07
    2003
    Registered Principal Register
  • Aug 08
    2003
    Allowed Principal Register SOU Accepted
  • Jul 29
    2003
    Assigned To Examiner
  • Jul 24
    2003
    Case File In TICRS
  • Jun 26
    2003
    Statement Of Use Processing Complete
  • May 01
    2003
    Use Amendment Filed
  • Jun 05
    2003
    Extension 1 Granted
  • Apr 11
    2003
    Extension 1 Filed
  • May 01
    2003
    TEAS Statement Of Use Received
  • Apr 11
    2003
    TEAS Extension Received
  • Mar 18
    2003
    NOA Mailed SOU Required From Applicant
  • Dec 24
    2002
    Published For Opposition
  • Dec 04
    2002
    Notice Of Publication
  • Oct 24
    2002
    Approved For PUB Principal Register
  • Oct 11
    2002
    Assigned To Examiner